AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $128,281 | -3.2% | 16,510 | +20.5% | 0.00% | – |
Q2 2023 | $132,584 | +56.4% | 13,697 | +77.1% | 0.00% | – |
Q1 2023 | $84,751 | +70.4% | 7,733 | -32.6% | 0.00% | – |
Q4 2022 | $49,734 | -47.6% | 11,476 | -9.1% | 0.00% | – |
Q3 2022 | $95,000 | -43.5% | 12,629 | -24.9% | 0.00% | – |
Q2 2022 | $168,000 | -26.3% | 16,819 | -9.1% | 0.00% | – |
Q1 2022 | $228,000 | -49.9% | 18,493 | -7.5% | 0.00% | -100.0% |
Q4 2021 | $455,000 | +15.2% | 19,986 | +11.7% | 0.00% | 0.0% |
Q3 2021 | $395,000 | -11.0% | 17,890 | -47.9% | 0.00% | 0.0% |
Q2 2021 | $444,000 | +75.5% | 34,359 | +77.0% | 0.00% | 0.0% |
Q1 2021 | $253,000 | -59.7% | 19,413 | -57.2% | 0.00% | -50.0% |
Q4 2020 | $628,000 | +120.4% | 45,391 | +134.8% | 0.00% | +100.0% |
Q3 2020 | $285,000 | +2.9% | 19,330 | +13.5% | 0.00% | 0.0% |
Q2 2020 | $277,000 | +166.3% | 17,030 | +136.5% | 0.00% | – |
Q1 2020 | $104,000 | – | 7,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |